PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
about
Prostacyclin-dependent apoptosis mediated by PPAR deltaTranscription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesisGene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis.Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiationChronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistanceCellular Reprogramming Using Defined Factors and MicroRNAsHypercholesterolemia induces adipose dysfunction in conditions of obesity and nonobesityLipid biology of breast cancerCOX-2 and cancer: a new approach to an old problemIdentification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobeActivation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cellsA plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiationInhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetesMechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty ratsSynergic effect of vitamin A and high-fat diet in adipose tissue development and nuclear receptor expression in young ratsCooperation between C/EBPalpha TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiationHic-5 regulates an epithelial program mediated by PPARgammaTranscriptome-Wide Analysis Reveals the Role of PPARγ Controlling the Lipid Metabolism in Goat Mammary Epithelial CellsAdiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromePreventive effects of puerarin on alcohol-induced osteonecrosis.Dipeptidyl peptidase IV inhibitor lowers PPARγ agonist-induced body weight gain by affecting food intake, fat mass, and beige/brown fat but not fluid retentionPeroxisome proliferator-activated receptor delta (PPARdelta )-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling.Cotranscription and intergenic splicing of the PPARG and TSEN2 genes in cattleCurcumin suppresses PPARdelta expression and related genes in HT-29 cellsPPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells.Induction of human embryonic and induced pluripotent stem cells into urothelium.Proteomic analysis of epicardial and subcutaneous adipose tissue reveals differences in proteins involved in oxidative stress.Classification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and ObesityLow birth weight male guinea pig offspring display increased visceral adiposity in early adulthood.Downregulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potentialPancreatic fat accumulation, fibrosis, and acinar cell injury in the Zucker diabetic fatty rat fed a chronic high-fat diet.Novel PPARγ partial agonists with weak activity and no cytotoxicity; identified by a simple PPARγ ligand screening system.Water-soluble extract of Pacific Krill prevents triglyceride accumulation in adipocytes by suppressing PPARγ and C/EBPα expressionRunx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonistsFat tissue, aging, and cellular senescence.The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation.Impaired adipogenesis and lipolysis in the mouse upon selective ablation of the retinoid X receptor alpha mediated by a tamoxifen-inducible chimeric Cre recombinase (Cre-ERT2) in adipocytesGut bacteria alteration in obese people and its relationship with gene polymorphism.Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.
P2860
Q24291677-76683C07-8602-4F99-85B7-AAE01488D71CQ24298511-5CD61189-2404-4C6F-B809-0636DC426524Q24301803-77B2FD95-BB88-4B86-B1F9-AE58BA36D501Q24553023-4ED37F14-7866-43A3-89C9-92BBE8F2EE98Q24617743-3592A92E-1FAB-4401-AF9B-33EA55D955A6Q26744303-9909B3FA-ECA2-44A3-9225-84AC57813549Q26992274-1C489255-F453-4A22-BDAD-09AD784239CBQ27013858-90CA615A-5FDC-4C68-AE19-648308A218D7Q28191533-B7E286C8-2200-41EA-9282-B4A5208827B4Q28211498-1632A10E-2AE5-4E00-81D9-183978837E97Q28214426-C111E526-6E91-4F25-85F5-076E59FD6BB6Q28357136-553C0A27-35D4-4366-8D9D-4762DA1AB0A9Q28360697-588C72DE-A625-4101-832A-69A49149C958Q28567397-9F7D05BC-10E7-4E7C-BDAD-99E08E803824Q28577501-3A0548AF-7CDC-4992-9DBE-30DC34324785Q28580573-41D52F9B-9832-461F-B3E5-D5FE440FBCC3Q28586821-E0E42B29-C4B2-4326-AB04-C4BD7838F068Q28820990-DB0F7DCA-87C5-4AF9-96E4-9D390267CFB8Q29619211-2AD7F7AF-FBA3-4265-85D1-78D54145DF15Q30439726-987FE212-9062-459C-AE42-7218520E78F4Q30717371-D50E14C8-19B7-441A-BD5C-AEACD059D433Q31537639-1D323AE7-C28B-48AA-986D-99B314CEF59FQ33238892-4438F05C-E9C7-4D30-81BC-B0FFB6B9187AQ33419214-FC2B4FE7-9BE6-452B-A0C9-841ADFF07C49Q33515919-7130E759-84B2-4023-80CA-AD49EF47BDE1Q33551978-C38D3B4B-FE83-4F23-9A7F-E019FFF2F7AEQ33570051-AA08D360-97B7-4B12-A796-02FD86C8F762Q33659194-5E778E88-1F69-4F5B-B302-CB7706F8E40FQ33753235-D357708E-2A58-4622-924B-AB6939D36E9DQ33797094-04784463-929B-4427-A7D8-0A4F8A4E44B2Q33825167-F9C674C3-C689-462B-952A-648ABDAFB7C2Q33935032-D22F73EE-31E0-49F8-B51D-E462C58E1DEBQ33961628-48D5F86C-338A-4922-9052-63AD1940E3FAQ33966602-97B52943-98A9-4AF2-B58F-304B52561561Q34011043-F6069B90-2E5D-4088-A7B3-E89F664AE372Q34130783-8DF8312A-6EBC-46B6-9C29-F2A9E29EF287Q34249837-5E17A754-2F36-4383-8275-0C1F67DCADC3Q34591652-832778F5-15D3-478D-91E9-7F4E3ED274C1Q34670929-16C3CFB6-3D9A-4951-902A-DEAB03B2BCD4Q34695413-16578040-35E9-44DD-A485-EB367549178B
P2860
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@ast
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@en
type
label
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@ast
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@en
prefLabel
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@ast
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@en
P1433
P1476
PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
@en
P2093
P304
P356
10.1016/S0092-8674(00)81654-2
P407
P577
1999-10-01T00:00:00Z